Clinical trial Recruiting at 1 site Observational Ages 35 to 90

Will GFAP in the blood after carotid endarterectomy predict neurological problems?

Official title: Investigation of the Association Between Perioperative Glial Fibrillary Acidic Protein Levels and Postoperative Neurological Complications After Carotid Endarterectomy

Run by Bursa Yuksek Ihtisas Training and Research Hospital · NCT07843979 · Data updated 2026-11-12

This study tests whether blood GFAP levels before and after carotid endarterectomy relate to postoperative neurological issues in adults.

More Carotid Stenosis trials

Quick facts

Study typeObservational
Ages35 Years to 90 Years
SexAll
Enrollment90 (estimated)
SponsorBursa Yuksek Ihtisas Training and Research Hospital
Government
Locations1 site (Bursa, Bursa)
StatusRecruiting
StartedDecember 15, 2025
Main results expectedDecember 1, 2026
Study endsDecember 1, 2026
Registry record updatedSeptember 28, 2026
Trial IDNCT07843979 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 35–90 undergoing elective isolated carotid endarterectomy who consent and can provide a blood sample.

Probably not a fit

Patients who do not develop neurological complications or whose GFAP levels do not correlate with outcomes may not benefit from this information.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, single-center observational study will measure serum GFAP before surgery and 24 hours after carotid endarterectomy to see if levels associate with postoperative neurological complications. Researchers will collect perioperative data and monitor for events such as TIA, stroke, delirium, and cognitive dysfunction. Analyses will compare those who develop neurological issues with those who do not, using univariable and multivariable models. No treatment will be assigned; care is determined by the treating team. About 90 participants are planned at a single hospital.

Why it matters

Potential benefit: If successful, the study could help identify patients at higher risk of neurological problems after surgery using a simple blood test.

How similar studies have gone: Prior research has explored GFAP as a biomarker for brain injury, with mixed results; this study adds focused perioperative data in carotid endarterectomy patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 35 to 90 years
* Scheduled to undergo elective isolated carotid endarterectomy
* Willing and able to provide informed consent and the required blood samples

Exclusion Criteria:

* Acute coronary syndrome within the previous 3 months
* Carotid endarterectomy planned in combination with another surgical procedure
* Atrial fibrillation
* Known inflammatory disease
* Hematologic disease
* Refusal to provide preoperative consent or a blood sample
* Stroke with residual neurological sequelae within the previous year
* Multiple sclerosis, Alzheimer disease, Parkinson disease, or another pre-existing neurological disease

Where it's running

  • University of Health Sciences Bursa Yuksek Ihtisas Training and Research Hospital
    Bursa, Bursa, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.